Zio Patch detected SVT in 7% and VT in 3% of 3,815 pediatric patients, with 57% of arrhythmias identified after 24 hours of monitoring.
What is the prevalence of supraventricular tachycardia and ventricular tachycardia detected by the Zio Patch in pediatric patients?
Prolonged ambulatory ECG monitoring with the Zio Patch effectively detects clinically significant arrhythmias in pediatric patients, with the majority of arrhythmias identified beyond the traditional 24-hour monitoring window.
Absolute Event Rate: 0% vs 0%
Abstract Background Cardiac arrhythmias are infrequent in the pediatric population, and most children with arrhythmias only exhibit symptoms when underlying conditions are present. However, timely and accurate detection of clinically significant arrhythmias, such as supraventricular tachycardia (SVT) and ventricular tachycardia (VT), is essential for early intervention and management. The Zio Patch, a wearable, continuous ECG monitor, has garnered attention as a promising non-invasive tool for prolonged arrhythmia monitoring. Its ability to detect arrhythmias over extended periods offers a potential advantage over traditional short-term monitoring methods, especially in pediatric patients. Purpose This systematic review and single-arm meta-analysis aim to assess the prevalence of SVT and VT in pediatric patients detected by Zio Patch, examining the diagnostic utility of this technology in identifying arrhythmias that may otherwise go undiagnosed in this population. Methods PubMed, Scopus, and Cochrane Central databases were systematically searched in February 2025 for observational studies involving pediatric patients who underwent Zio Patch monitoring. Only studies reporting the outcomes (1) SVT and (2) VT were included. A single-arm meta-analysis was performed using R version 4.4.2. Study heterogeneity was assessed using Cochran’s Q test and I² statistic. Detection rates for SVT and VT were analyzed using McNemar’s test, while wear time was evaluated using the Wilcoxon signed-rank test. Results Three studies met the inclusion criteria, involving 3,815 pediatric participants. The mean age of participants was 13.1 years, with 57% male. The mean time to detect an arrhythmia across the studies was 36.2 hours, with the mean wear time of the Zio Patch being 130.7 hours. The prevalence of VT was 3% (95% CI: 0.02–0.05), and the prevalence of SVT was 7% (95% CI: 0.06–0.08). Importantly, 57% of detected arrhythmias occurred after the first 24 hours. Conclusions The Zio Patch proves to be a valuable tool in the detection of clinically significant arrhythmias, such as SVT and VT, in the pediatric population. Its ability to detect arrhythmias beyond the first 24 hours, in a population where such conditions are relatively rare, makes it an effective ambulatory ECG monitoring option. Given its extended monitoring capabilities, the Zio Patch offers a unique advantage in identifying arrhythmias that may otherwise be missed by traditional methods. These findings highlight the importance of incorporating advanced monitoring technologies in clinical practice, particularly in children with underlying heart conditions, underscoring the Zio Patch’s advantage over traditional short-term monitoring methods.Forest plot for prevalence of VT Forest plot for prevalence of SVT
Akabane et al. (Sat,) reported a other. Zio Patch detected SVT in 7% and VT in 3% of 3,815 pediatric patients, with 57% of arrhythmias identified after 24 hours of monitoring.